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(57) ABSTRACT 
Multifunctional "smart" nanostructures are disclosed that 
include fluorescein isothiocyanate (FITC)-encapsulated Si02 
core-shell particles with a nanoscale ZnO finishing layer, 
wherein an outer ZnO layer is formed on the Si02 - FITC core. 
These -200 nm sized particles showed promise toward cell 
imaging and cellular uptake studies using the bacterium 
Escherichia coli and lurkat cancer cells, respectively. The 
FITC encapsulated ZnO particles demonstrated excellent 
selectivity in preferentially killing lurkat cancer cells with 
minimal toxicity to normal primary immune cells (18% and 
75% viability remaining, respectively, after exposure to 60 
flglmL) and inhibited the growth of both gram-positive and 
gram-negative bacteria at concentrations ~250-500 flg/mL 
(for Staphylococcus aureus and Escherichia coli, respec-
tively). These results indicate that the FITC encapsulated 
multifunctional particles with nanoscale ZnO surface layer 
can be used as smart nanostructures for particle tracking, cell 
imaging, antibacterial treatments and cancer therapy. 
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FLUORESCENT PARTICLES COMPRISING 
NANOSCALE ZNO LAYER AND EXHIBITING 
CELL-SPECIFIC TOXICITY 
2 
Escherichia coli (E. coli) and Staphylococcus aureus (s. 
aureus) bacteria were completely killed by ZnO nanopar-
ticles at concentrations ~3.4 mM and ~1.0 mM, respec-
tively, with minimal effects on primary hnman T cells. More 
recent experiments have shown that these nanoparticles have 
superior ability to kill both lurkat and Hut-78 cancer cells at 
micromolar concentrations at which normal cells displayed 
no measurable cell death. Such an order of magnitude differ-
ence in toxicity to cancer cells relative to normal host T-cells 
This application claims priority of Provisional Application 5 
No. 601974,461, filed Sep. 22, 2007, and entitled "Fluores-
cent Dye Encapsulated ZnO Particles with Cell-Specific Tox-
icity for Cancer Treatment and Bio-medical Applications," 
the entire disclosure of which is hereby incorporated herein 
by this reference. 10 makes ZnO nanoparticles a potential candidate for cancer therapy. Based on these interesting results, we have devel-
oped a core-shell structure with fluorescent FITC encapsu-
lated in Si02 as the core and nanoscale ZnO as a surface layer, 
hereafter referred as FITC-ZnO. These FITC-ZnO particles 
This research was supported in part by NSF-Idaho-EPS-
CoR Program (EPS-0447689), DoE-EPSCoR grant (DE-
FG02-04ER46142), NSF -CAREER award (DMR -0449639), 
NSF-MRI grants (MRI-052131, MRI-0619793 and MRI-
0722699), and NIH awards (lRI5AI06277-01Al, lR43 15 
AR052955-0l and P20RROI6454). 
were synthesized using a novel one-pot methodology involv-
ing successive hydrolysis and condensation of FITC-linked 
silicate and zinc salt. The synergistic effects of ZnO and Si02 
BACKGROUND OF THE INVENTION 
1. Field of the Invention 
This invention relates generally to a new composition of 
matter, a zinc oxide (ZnO) encapsulated fluorescent dye 
nanoparticle in about the 200 nm range, with the ZnO outer 
layer being about 10 nm. More specifically, this invention 
relates to use of the new nanoparticle material as a fluores-
cence probe, antibacterial agent, or cancer treatment. Also, 
this invention relates to ways to make the new material. 
2. Background Art 
nanostructures on the optical properties of the fluorophores 
and the toxic nature of the resulting nanostructures are 
explored in detail. Moreover, although reactive oxygen spe-
20 cies generated at the surface of excited nanomaterials are 
generally thought to be responsible for observed biocidal 
effects, the detailed mechanism of toxicity and their selective 
nature to different biological systems still remains poorly 
understood. Adding fluorescence functionality to the ZnO 
25 nanostructures will aid future detailed in vitro and in vivo 
studies necessary to understand the fundamental interaction! 
uptake mechanism as well as improve our ability to evaluate 
and efficiently utilize the therapeutic potential of ZnO nano-
particles. The present work focuses on the preparation and 
characterization of fluorescent FITC-ZnO particles with an 
30 untouched outer ZnO nanolayer and their ability to selec-
tively kill certain types of cancer cells and bacteria. However, 
no attempt is made in this work to address the mechanism of 
cell-particle interactions and toxicity. These will be the sub-
The ongoing worldwide nanotechnology revolution is pre-
dicted to impact several areas of biomedical research and 
other science and engineering applications. Nanoparticle-as-
sisted drug delivery, cell imaging and cancer therapy are 
important biomedical applications of nanotechnology. Devel-
opment of core-shell nanostructures that combine multiple 
functions are of great interest for future nano-bio-technology 35 
and biomedical applications. For example, core-shell nano-
structures containing a chemotherapeutic drug and a fluores-
cent dye could be used to release the drug at sites of interest 
while tracking the exact location of its delivery using imaging 
methods employing the fluorescence of the dye molecules. 
When organic dye molecules such as fluoroescein isothiocy-
anate (FITC) are exposed to harsh environments, they often 
suffer from freely interacting with solvent molecules, which 
can result in reduced performance of the dye. Encapsulation 
ject matter of future publications. 
Semiconducting ZnO has good chemical stability, wide 
direct band-gap (Eg=3.37 eV) and large excitation binding 
energy (60 meV), and has been studied for nnmerous appli-
cations including nanodevices, light-emitting diodes, sen-
sors, luminescence, and photovoltaics. Thus the ZnO surface 
40 layer of these novel core-shell FITC-ZnO nanostructures has 
the added benefit of providing a robust platform for many 
future applications. For example, Dorfman et al. (A. Dorf-
man, N. Kumar, 1. Hahm, Langmuir, 22, 4890 (2006); and A. 
Dorfman, N. Kumar, 1. Hahm, Adv. Materials, 18, 2685 
of the organic fluorescent dye in a core-shell nanostructure 
can not only add optical functionality, allowing the particles 
to be tracked and imaged easily, but can also enhance the 
stability and performance of the dye by protecting it from 
photobleaching and quenching from the background 
medium. 
Several groups have employed fluorescent core-shell nano-
particles to add functional layers that can destroy disease 
causing cells, including cancerous cells. Mesoporous fluores-
cent silica particles developed by adding molecular sieve 
materials such as MCM-48 were used for site-oriented deliv-
ery of chemotherapeutic drugs and cell imaging. Recently, 
gold coated silica nanoparticles have been used to kill tumor 
cells via hyperthermia treatments. However, these treatment 
methods employing either the conventional chemotherapeu-
tic drugs or hyperthermia suffer from lack of significant cell 
specificity. Both methods can kill normal cells along with 
cancer cells of interest. 
In a recent work (K. M. Reddy, K. Feris, 1. Bell, D. G. 
45 (2006)) developed nanoscale ZnO platforms for use as attrac-
tive substrates in fluorescence bioassays using FITC labels. 
They found that ZnO nanorod substrates could significantly 
enhance the fluorescence detection capability of proteins and 
nucleic acids without any need for amplification of detection 
50 signal. Moreover, ZnO nanocrystalslquantum dots might pro-
duce UV and visible fluorescence. Thus, addition of a stable 
surface layer of ZnO on the fluorescent FITC-Si02 cores will 
provide the core-shell particles with two different fluores-
cence sources. Changes in the ZnO fluorescence when bio-
55 logical species are attached to the outer surface could provide 
opportunities for bio-sensing and the internal FITC fluores-
cence could serve as a reference standard to quantify relative 
change in intensity and the surface attached species. To the 
best of our knowledge, preparation and characterization of 
60 fluorescent dye encapsulated particles with an active ZnO 
finishing layer and their preferential cancer killing and bac-
terial inhibiting ability have not yet been reported. 
Wingett, C. Hanley, A. Puunoose, Appl. Phys. Lett. 90, 
213902 (2007)), our group demonstrated the ability of iden- 65 
tical-13 nm ZnO nanoparticles to kill bacterial cells at con-
centrations that are not toxic to human T lymphocytes. 
SUMMARY OF THE INVENTION 
Fluorescein isothiocyanate (FITC)-encapsulated Si02 
core-shell particles with a nanoscale ZnO finishing layer have 
US 7,939,560 B2 
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been synthesized for the first time as multifunctional "smart" 
nanostructures. Detailed characterization studies confirmed 
the formation of an outer ZnO layer on the Si02 -FITC core. 
These -200 nm sized particles showed promise toward cell 
imaging and cellular uptake studies using the bacterinm 5 
Escherichia coli and 1urkat cancer cells, respectively. The 
FITC encapsulated ZnO particles demonstrated excellent 
selectivity in preferentially killing 1urkat cancer cells with 
minimal toxicity to normal primary immune cells (18% and 
75% viability remaining, respectively, after exposure to 60 10 
flg/mL) and inhibited the growth of both gram -positive and 
gram-negative bacteria at concentrations ~250-500 flg/mL 
(for Staphylococcus aureus and Escherichia coli, respec-
tively). These results indicate that the novel FITC encapsu-
lated multifunctional particles with nanoscale ZnO surface 15 
layer can be used as smart nanostructures for particle track-
ing, cell imaging, antibacterial treatments and cancer therapy. 
phine oxide (TOPO), 1.0 g polyethylene glycol (PEG), and 
0.5 mL ofFITC-APTMS were added to a flask containing 200 
mL of diethylene glycol (DEG) solution and stirred for 10 
min. Then, 0.5 mL oftetraethylorthosilicate (TEOS), 2.0 mL 
of water, and 1.5 mL of ammoninm hydroxide (28-30%) were 
added into the above mixture and stirred for 1.5 h to form 
FITC-Si02 cores. A part of this sample was separated at this 
point to obtain FITC encapsulated silica particles to compare 
their properties with FITC encapsulated ZnO particles. The 
resulting mixture was then heated to 100° C. and 2.6 g of Zinc 
acetylacetonate, Zn(CH3 COCHCOCH3 )2 was introduced. 
Following this, the mixture was heated to 160° C. and main-
tained at that temperature for 2 h. The heating was then 
stopped to allow the mixture to cool down to room tempera-
ture with continuous stirring for 1 h. The resulting FITC-ZnO 
particles were purified by centrifugation at 10,000 rpm for 8 
min. The supernatant was removed and replaced with ethanol. 
This process was repeated for several times until no yellow 
fluorescence of FITC was observed in the supernatant. Sub-BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a collection of two charts and two transmission 
electron microscopy (TEM) images of FITC-ZnO particles. 
FIG. 2 is a collection offour charts about X-ray photoelec-
tron spectroscopy (XPS) investigation of core-shell FITC-
ZnO particles. 
FIG. 3 is a chart about UV-vis-NIR absorption spectra of 
FITC-ZnO particles. 
FIG. 4 is a collection of four charts about fluorescence 
characterization of FITC-ZnO particles. 
FIG. 5 is a collection of three charts about flow cytometry 
examination ofFITC-ZnO particles. 
FIG. 6 is three microscopic cell images with FITC-ZnO 
particles. 
FIG. 7 is four microscopic images about uptake of FITC-
ZnO particles by 1urkat cancer cells. 
FIG. 8 is a collection of two charts about concentration and 
time-dependent cytotoxicity of FITC-ZnO particles for bac-
terial systems. 
FIG. 9 is a chart about concentration-dependent cytotox-
icity of FITC-ZnO particles for leukemia T cells and normal 
human T cells. 
DETAILED DESCRIPTION OF THE PREFERRED 
EMBODIMENTS 
Referring to the figures, there are shown some, but not the 
only, embodiments of the invented ZnO-encapsulated fluo-
rescent dye particles, preferably FITC-ZnO particles. In the 
description that follows are some, but not the only, invented 
methods of making and using said ZnO-encapsulated fluo-
rescent dye particles. 
Experimental Section 
Synthesis ofFITC-ZnO Particles: 
20 sequently, the resultant particles were dried in an oven. 
Characterization of Fluorescent FITC-ZnO Particles: 
The morphology, size, structure, and composition ofFITC-
ZnO particles were thoroughly investigated using transmis-
sion electron microscopy (TEM), X-ray diffraction (XRD), 
25 X-ray photoelectron spectroscopy (XPS), and UV-vis spec-
troscopy. (1. Hays, K. M. Reddy, N.Y. Graces, M. H. Engel-
hard, V. Shutthanadan, M. Luo, C. Xu, N.C. Giles, C. Wang, 
S. Thevuthasan, A. Punnoose, 1. Phys: Condens. Matter. 19, 
266203 (2007)). In addition to the as-prepared samples, XPS 
30 spectra were also collected after removing 2, 5, 8, and 11 nm 
thick layers successively viaAr+ ion sputtering using a 2 kV 
Ar+ ion beam rastered over a 4 mm diameter sample area 
during 2 RPM sample rotation. 
The fluorescence properties and stability of FITC-ZnO 
35 particles were studied using fluorescence spectroscopy and 
flow cytometry. For flow cytometric analysis, a 3-color Epics 
XL cytometer (Coulter, Miami, Fla.) was used to evaluate the 
photobleaching and quenching effects ofFITC-ZnO particle 
aggregates. FITC-ZnO particles were analyzed after keeping 
40 in oxygen-rich water for varying times, and in some cases, 
after subjecting the samples to illumination using a mercury 
lamp (Model SP200 spectrum tube, with 5000V and 10 rnA 
output) and then resuspended in oxygen-rich water prior to 
analysis, and a minimnm of 10,000 particle aggregates moni-
45 tored for changes in relative fluorescence using a 488 nm 
argon laser. 
Fluorescence spectra of FITC-ZnO particles were mea-
sured at room temperature using a Horiba 1 obin Yvon T 64000 
spectrometer equipped with Hamamatsu R943-02 GaAs pho-
50 tomultiplier. Two lines ofa He---Cd laser, 441.6 and 325 nm, 
were used for excitation. The photobleaching and quenching 
effects of the FITC-ZnO nanoparticles were investigated by 
measuring the fluorescence data at fixed time intervals after 
subjecting the samples to low power laser light (wavelength 
55 441.6 nm, power density -80 W cm-2 ). Similar data were also 
taken from pure FITC sample under identical conditions for FITC-ZnO particles were synthesized by forced hydrolysis 
and condensation of FITC-binding silane and silicate to 
obtain the FITC-Si02 core, followed by the formation of ZnO 
surface layer using zinc salt. In a typical synthesis, 10 mg 
(0.026 mmol) of FITC was dissolved in 3.0 mL ethanol by 60 
stirring for 20 min, followed by the addition of 20 flL (0.085 
mmol) of vacuum-distilled (3-aminopropyl)-trimethoxysi-
lane (APTMS). The reaction continued for 24 h under stirring 
comparison. 
Utility tests for cell imaging: The feasibility of using FITC-
ZnO particles for particle tracking/cell imaging in biological 
environments was investigated using fluorescence confocal 
image microscopy (FCIM). Stationary phase E. coli cells 
were exposed to FITC-ZnO particles and PI for 15 minutes at 
room temperature. FITC-ZnO and PI exposed cells were 
spotted on a glass slide, allowed to air dry, and viewed using 
a Zeiss LSM 5 Pascal confocal microscope. Additional slides 
were prepared with E. coli cells exposed to either the FITC-
ZnO particles or PI alone to determine ifthere was any over-
in the dark. The amino group of the APTMS reacts with the 
isothiocyanate group ofFITC to form N-l-(3-triethoxysilyl- 65 
propyl)-N'-fluoresceyl thiourea, and the resulting solution is 
referred to as FITC-APTMS. Second, 0.77 g tri-n-octylphos-
US 7,939,560 B2 
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lap in the fluorescence emission of the two dyes. The confocal 
microscope was configured to prevent detection ofFITC fluo-
rescence in the PI channel and vice versa. For cellular uptake 
and internalization studies, log phase lurkat cells were 
adhered to poly-d-lysine treated glass bottom chamber slides 5 
(MatTek, Ashland, Mass.), treated with 0.25 mM FITC-ZnO 
particles for 8 hours, washed three times in PBS/3% fetal 
bovine serum (FBS) to remove extracellular NP, stained with 
Results and Discussion 
Synthesis, Structure and Composition of the Multi-Layered 
Core-Shell Architecture: 
In this work, we have synthesized multifunctional fluores-
cent core-shell particles with a ZnO outer layer using a novel 
one-pot methodology of successive hydrolysis and conden-
sation ofFITC-incorporating silicate and zinc salt. This pro-
cedure is based on the methods used by several groups to 
synthesize colloidal silica particles encapsulated with organic 
a PE-conjugated antibody specific to the CD3 cell surface 
protein (Beckman Coulter, Miami, Fla.) as previously 10 
described using 8 fll/200 fll of cells, and washed a final time in 
PBS/3% FBS. For confocal analysis, control slides were pre-
pared to verify the absence of spectral overlap between the 
fluorophores (A. Bums, H. Ow, U. Wiesner, Chern. Soc. Rev. 
35, 1028 (2006); and H. Ow, D. R. Larson, M. Srivatsava, B. 
A. Baird, W. W. Webb, U. Wiesner, Nano Lett. 5, 113 (2005)), 
but modified to include the additional ZnO layer, as described 
in our earlier work. The novelty that this work brings to the 
two dyes after appropriate instrument set-up. 
Cancer/Anti-Bacteria Treatment Applications: 
Toxicity of the FITC-ZnO particles toward human T lym-
phocytes and lurkat cancer cells was determined as follows. 
First, peripheral blood mononuclear cells (PBMC) were 
obtained by Ficoll-Hypaque (Histopaque-1077, Sigma, St. 
Louis, Mo.) gradient centrifugation using heparinized blood 
samples from healthy volunteers. This cell mixture was 
washed 3 times with Hank's buffer (Sigma), and incubated at 
1.0x106 cells/mL in RPMI-1640 (Sigma) containing 10% 
fetal bovine serum. CD4+ T cells were subsequently isolated 
using negative immunomagnetic selection per manufactur-
er's instructions using a cocktail of antibodies against 
CD45RO, CD8, CD19, CD14, CD16, CD56, CD8, and gly-
cophorin A (StemCell Technologies, Vancouver, B.e.) with 
collection of unlabeled T cells (typically >96% CD4+ and 
>93% viable as assessed by flow cytometry). Purified CD4 + T 
cells, or the lurkat T cell line (ATCC, Rockville, Md.) were 
cultured in RPMIIlO% FCS at 5x105 cells/mL in 96-well 
microtiter plates and treated with various concentrations of 
FITC-ZnO particles resuspended in PBS. For the delivery of 
FITC-ZnO particles to cell cultures, a stock solution was 
made and sonicated for 10 minutes. Then immediately prior 
to dispensing into each individual cell culture well, particles 
were vortexed and immediately dispensed. This process was 
repeated for each culture well, to reduce differential particle 
delivery due to sedimentation. After 24 h of culture, cells 
were stained with propidium iodide (PI; BD Biosciences, San 
lose, Calif.) to monitor loss of membrane integrity as previ-
ously reported and 10 flL of fluorescently labeled micro-
spheres (Molecular Probes, Eugene, Oreg.) added to each 
sample to allow for the absolute detennination of cell num-
bers. Flow cytometry was used to analyze a minimum of 
10,000 T cells per sample to determine changes in PI staining 
and quantification of cell death. 
15 field is the addition of the outer ZnO nanolayer to the FITC 
encapsulated silica that display an additional functionality of 
selective toxicity to certain types of bacteria and cancer cells. 
In the following, we demonstrate that the particles have a 
core-shell structure and they maintain the fluorescence prop-
20 erties of the encapsulated dye and the selective toxicity of the 
outer ZnO nanolayer. 
The FITC encapsulated fluorescent ZnO particles were 
light orange in color. FIG. 1 (panels labeled A-D) shows 
X-ray diffraction patterns and HRTEM images of core-shell 
25 FITC-ZnO particles. FIG. lA illustrates X-ray diffraction 
spectra of FITC-ZnO particles, along with those of pure 
samples of PEG, FITC, ZnO and Si02 particles, wherein a 
schematic illustration of the FITC-ZnO particles is shown in 
the inset of FIG. lA. FIG. IB shows TEM images of FITC-
30 ZnO particles, where the inset on the left shows a group of 
FITC encapsulated ZnO particles and the right inset shows a 
TEM image of the FITC encapsulated Si02 particles taken 
out during the synthesis ofFITC-ZnO particles. FIG. lC is a 
plot showing the size distribution ofFITC-ZnO particles, and 
35 FIG. ID is a high-resolution TEM image of the outer shell of 
the FITC-ZnO particles illustrating the ZnO crystallites form-
ing the outer layer. 
The inset ofFIG.IA shows the schematic representation of 
the particle with the expected core-shell structure. X-ray dif-
40 fraction (XRD) measurements were used to investigate the 
material composition and chemical phases present in the 
FITC-ZnO particles, comparing to those of pure samples of 
Si02 and ZnO particles prepared under similar conditions. 
The XRD spectrum of the FITC-ZnO particles shown in FIG. 
45 lA clearly has all the expected ZnO peaks in addition to the 
strongest peaks of polyethylene glycol (PEG) used for size 
control and capping agent for Si02 , and for improving the 
hydrophilicity ofFITC-ZnO particles. Only a broad peak was 
observed for Si02 indicating poor crystallinity. Average size 
50 of the ZnO crystallites were estimated using the Scherrer 
equation, L=0.9A/~ cos 8 (where 8 is the XRD peak position, 
A is the x-ray wavelength and ~ is the width of the measured 
peak after correcting instrumental width). The estimated size 
of -10 nm suggests that the outer ZnO layer was fonned by 
Similar toxicity studies ofFITC-ZnO particles on bacteria 
were conducted. FITC-ZnO particles were resuspended in 
sterile 0.9% NaCl aqueous solution, then sonicated for 15 
minutes in a bath sonicator and continuously agitated by 
pipetting prior to dispensing to LB media for toxicity testing. 
For inhibitory threshold detennination resuspended FITC-
ZnO particles were added to Luria-Bertani (LB) agar to dif-
ferent final concentrations (0-1250 DglmL), as described in 60 
our earlier work. Time dependent toxicity tests were per-
formed as follows. Equal densities of overnight E. coli cul-
tures (based on OD600nm values) were used to inoculate LB 
broth with and without FITC-ZnO particles. Broth cultures 
were incubated with shaking as above, sampled repeatedly, 65 
and viable cell densities measured via CFU enumeration by 
plating on particle free LB media. 
55 attaching such nanocrystals on the surface ofFITC encapsu-
lated Si02 structures. Transmission electron microscopy 
(TEM) measurements were performed to investigate the par-
ticle size, shape and size distribution of the fluorescent FITC-
ZnO particles. 
FIG. IB shows spherical FITC-ZnO particles of average 
size -200 nm and with a size distribution shown in FIG. Ie. 
The TEM data also confirms the XRD result that the surface 
ZnO layer is formed via accumulation of -1 0 nm sized ZnO 
crystallites (FIG. ID). The presence of the relatively less 
electron transparent ZnO nanoparticle layer on the outer sur-
face prevented clear observation of the core-shell structure. 
To obtain better insight on this, a part of the sample was 
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separated during the synthesis process before adding the ZnO 
precursor. This provided FITC encapsulated silica particles 
before attaching the ZnO nanolayer on their surface. TEM of 
these FITC-Si02 particles showed an electron transparent 
core region (brighter region) presumably containing the FITC 5 
and the spherical silica shell (darker region) as shown in FIG. 
1B (top right inset). 
X-ray photoelectron spectroscopy (XPS) measurements 
were carried out to investigate the core-shell architecture of 
the fluorescent ZnO particles through layer-by-layer sputter- 10 
ing. FIG. 2 (panels labeled A-D) shows XPS investigation of 
core-shell FITC-ZnO particles, wherein FIG. 2A shows the 
XPS survey spectra of as-prepared FITC-ZnO particles and 
the same after removing 11 nm using Ar ion sputtering, a 
"whole survey spectrum." FIGS. 2B, C and D show the high- 15 
resolution XPS spectra of the Zn 2P3/2' Si 2p, and N 1 s 
regions, respectively, collected from as-prepared samples as 
well as from samples after successively removing 2, 5, 8 and 
11 nm thick layers. Thus, FIGS. 2B-D show the high resolu-
tion core level spectra of the Zn 2P3/2 (FIG. 2B), Si 2p (FIG. 20 
2C) and N 1 s (FIG. 2D) regions, which are representative and 
distinct constituents of the ZnO, Si02 and FITC layers. FIG. 
2B shows the Zn 2P3/2 peak at 1021.4 eV which is the 
expected binding energy range for pure ZnO. The observed 
increase in the peak intensity on going from the surface of the 25 
as-prepared particles to 8 nm deep indicated more efficient 
packing of ZnO crystallites with increasing depth. However, 
further sputter removal up to 11 nm showed a drastic reduc-
tion in the peak intensity and -1.0 eV increase in the binding 
energy. This is indicative of a significant change in the chemi - 30 
cal environment, most likely a transition from the ZnO sur-
face layer to a Si02 inner layer. Based on the observed pres-
ence of Zn in particles that underwent an 11 nm sputter 
removal and considering the ~12 nm analysis depth, an 
approximate thickness of 11-23 nm may be estimated for the 35 
ZnO surface layer. This estimate matches with the conclusion 
from the TEM and XRD data that the surface ZnO layer was 
formed by attaching -10 nm sized ZnO crystallites on the 
Si02 surface. These results are further confirmed by the Si 2p 
peaks shown in FIG. 2C. Weaker Si 2p peaks are present even 40 
in the as-prepared samples. The nominal analysis depth of 
XPS is in the ~12 nm range and therefore, if the Si02 layer 
starts about 8-12 nm below the particle surface, a weak Si 2p 
signal from the outer walls of the Si02layeris expected in the 
as-prepared sample as well as in samples after removing few 45 
nm thick layers. However, similar to the case of Zn 2P3/2 data 
shown in FIG. 2B, the Si 2p peak also shows dramatic 
changes when a 11 nm thick layer is removed from the sample 
(FIG. 2C). The Si 2p signal intensity increases significantly 
and shifts to higher energies by 1.4 eY. This large shift indi- 50 
cating a significant increase in the Si 2p binding energy can be 
attributed to the covalent bonding ofSi ions on the inner walls 
of the Si02 layer with FITC molecules. 
Recalling that FITC is bound covalently to the silica matrix 
via the (3-aminopropyl)-trimethoxysilane (APTMS) cou- 55 
pIing agent, the results shown in FIGS. 2B and 2C indicate a 
layered structure of the order of ZnO-Si02-APTMS-FITC 
as we proceed from the surface to the core of the FITC-ZnO 
particle. At the boundaries of these different layers, some 
level of mixed interface is also expected. The N Is peak 60 
arising from the FITC molecules shown in FIG. 2d further 
support the presence of such a layered architecture for the 
FITC-ZnO particles. Unlike the Si 2p peak, no N Is peak 
(397.8 eV) was observed in the as-prepared samples suggest-
ing that a measurable concentration of FITC molecules are 65 
not present in the surface region of the particles, at least in the 
~ 12 nm analysis depth range ofXPS. The complete absence 
8 
of this peak in as-prepared samples as well as in the ones after 
the sputter removal of up to 8 nm, and its subsequent strong 
presence after removing 11 nm confirm that FITC is mostly 
concentrated in the core of the particles. However, since the 
amino group of the APTMS reacts with the isothiocyanate 
group of FITC and this coupled FITC-APTMS participates 
with tetraethylorthosilicate (TEOS) in the hydrolysis/con-
densation reactions, some distribution of FITC molecules in 
the silica shell, especially in the inner layer is a likely possi-
bility. 
The binding energy shifts of the Zn 2P3/2 peak and the Si 2p 
peak in the 11 nm sputter removed sample are not due to any 
random changes or charging effects because (i) the sample 
charging has been continuously compensated during the sput-
tering process by comparing the effect on known standards, 
(ii) if the binding energy shifts are due to any charging effect, 
it should display a gradual and systematic shift as sputtering 
(or charging) progresses, (iii) the peak shifts at 11 nm sput-
tering is associated with large changes in the intensities also 
indicating that the effect is related to transition between layers 
and the associated changes in the concentration of the 
elemental constituents, and (iv) the change in the XPS peaks 
at 11 nm sputtering coincides with the appearance of the N 1 s 
signal from the FITC layer, again suggesting that the 
observed binding energy changes are associated with changes 
in the chemical environmentlbinding as data is collected pro-
gressively from different layers. 
The optical properties ofFITC-ZnO particles in water were 
studied using UV-vis-NIR spectrophotometry in the absorp-
tion mode. The spectrum of the FITC encapsulated ZnO 
samples was the sum of the spectral features observed in pure 
samples of -10 nm ZnO particles, -150 nm Si02 and pure 
FITC measured separately, as illustrated in the absorption 
spectra in FIG. 3. FIG. 3 discloses UV-vis-NIR absorption 
spectra ofFITC-ZnO particles. The optical spectra ofFITC-
ZnO particles dispersed in water (40 mg/mL) along with pure 
samples of FITC (1.2xlO-6 M), ZnO and Si02, and of the 
FITC-ZnO particles after treatment of 1.5% NaOH to release 
the encapsulated FITC by dissolving the ZnO-Si02 shells 
(NaOH treated FITC-ZnO). 
The features near 362 nm in pure ZnO and FITC-ZnO are 
the well expected absorption edges corresponding to the band 
gap of ZnO. The absorption peak at 489 nm of the encapsu-
lated FITC molecules was lower than 494 nm observed for 
pure FITC. This small blue shift could be the result of cova-
lent binding of the FITC molecules on the silica shell as also 
evident from the XPS data discussed earlier, and/or the pres-
ence of electron rich ZnO surface layer that might electro-
magnetically interact with the fluorophore. The charges in 
ZnO and/or near the polar ZnO-Si02 interface might give 
rise to long-range electrostatic potential, which might extend 
through the silica layer to the FITC core. Another possible 
reason might be a direct binding of a fraction of the FITC 
molecules distributed in the silica shell (through the pores 
present in the silica layer) with ZnO nanocrystals. Addition-
ally, UV-vis-NIR measurements were conducted for the 
FITC-ZnO particles after treating with 1.5% NaOH to release 
the encapsulated dye. The NaOH addition dissolves the ZnO 
layer as evident from the disappearance of the band edge 
(FIG. 3). From this experiment, itwas found that 40 mg/mL of 
the FITC-ZnO particles dispersed in water might have encap-
sulated FITC equivalent to 1.2x 1 0-6 M ofFITC, estimated by 
comparing the UV absorbance with that of pure dye solution. 
Fluorescent Emission Characteristics: 
The FITC-ZnO particles are capable of emitting strong 
fluorescence both in the visible and UV wavelength ranges 
originating from FITC and ZnO layers, respectively. FIG. 4 
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(panels labeled A-D) shows fluorescence characterization of 
FITC-ZnO particles, wherein FIG. 4A shows fluorescence 
emission spectra ofFITC-ZnO particles and FIG. 4B shows 
fluorescence emission spectra of pure FITC (1.2xlO-6 M), 
both of which were dispersed in oxygen-rich water and mea- 5 
sured as a function of time shown. FIG. 4C shows the com-
intensity versus the laser light exposure time (441.6 nm line), 
shown in FIG. 4D, suggests that the Si02-ZnO layer offers 
protection against photobleaching of the FITC molecules. 
The decay time constants to for pure FITC and the FITC-ZnO 
particles estimated from fitting the data shown in FIG. 4dwith 
exponential decay function e-tito were 17 and 27 minutes 
parison ofUV fluorescence spectra between FITC-ZnO par-
ticles and pure ZnO nanoparticles. The inset in FIG. 4C shows 
the FITC fluorescence from pure FITC, FITC encapsulated 
Si02 and FITC encapsulated ZnO; and the plot in FIG. 4D 
shows the relative decrease of fluorescence intensity as a 
function of exposure time for pure FITC sample and FITC 
encapsulated ZnO particles. 
Specifically, FIGS. 4A and 4B show the visible region 
fluorescence emission of FITC-ZnO particles and pure FITC 
(dispersed in water), respectively, excited by the 441.6 nm 
laser light. The encapsulation of FITC in the Si02 and ZnO 
layered shell might have caused a slight red shift and broad-
ening, as shown in the insert of FIG. 4C. Interestingly, dye 
encapsulated Si02 displayed a blue shift due to the covalent 
binding of the dye molecules as observed by other groups 
also. The change of the FITC fluorescence emission when the 
additional ZnO layer was added is attributed to the electro-
magnetic interactions between the ZnO layer and the FITC 
molecules and/or a direct binding of some FITC molecules 
distributed in the silica shell as discussed earlier. Colloidal 
metal layers on silica nanoparticles have been reported to 
exhibit plasmon resonance and can significantly modifY the 
fluorescence emission properties of the encapsulated dye 
molecules. The polar semiconducting ZnO surface layer 
might also have caused an electromagnetic interaction with 
FITC to exhibit the observed changes. Similar experiments 
employing a 325 nm UV laser produced strong UV fluores-
cence from ZnO layer shown in FIG. 4C. The peak emission 
from ZnO in FITC-ZnO particles is similar to that of -10 
nm-sized pure ZnO particles, but occurs at slightly longer 
wavelength (392 nm) compared to the emission from pure 
ZnO (387 n). This shift is most likely due to the presence of 
the Si02 layer and/or the binding ofFITC molecules present 
in the silica layer in close proximity. The UV laser and the 
resulting UV fluorescence from the ZnO layer also excite 
green fluorescence from the FITC dye, as can be seen in inset 
of FIG. 4C. Several groups have recently began developing 
ratiometric pH sensors which rely on the changes in the 
intensity, wavelength as well as other fluorescence character-
istics of a dye attached to the surface of a core-shell nanopar-
ticle due to analyte interactions. The inner dye encapsulated 
in the silica particles acts as an internal standard for the 
ratiometric analysis. Our demonstrated ability to integrate an 
additional layer of UV fluorescent ZnO thus provides the 
core-shell particles two fluorescence sources. By choosing 
appropriate dye molecules and layered architectures, ZnO 
based core-shell particles could also form efficient platforms 
for ratiometric sensing applications. 
The utility of fluorescent particles for tracking and imaging 
applications depends also on the environmental and photo-
stability of the fluorescence emission. The fluorescence emis-
sion of a fluorophore is often affected by the molecular inter-
action between the dye and various active species in the 
solvent such as dissolved oxygen. To investigate the environ-
mental and photo-stability, the FITC-ZnO particles were dis-
persed in oxygen-rich water and its fluorescence emission 
was recorded using a fluorescence spectrometer as a function 
of the time oflaser exposure, shown in FIG. 4A. The observed 
changes are compared to a similar measurement conducted 
on micromolar concentrations of pure FITC dissolved in 
water, shown in FIG. 4B. A plot of integrated fluorescence 
respectively. Evidently, the photo-stability ofFITC-Si02 par-
ticles reported by other groups is much more significant than 
our results. We believe that the reasons for this relatively 
10 weaker photo-stability might be the high concentration of 
FITC in the core of the particles and the less uniform distri-
bution of FITC in Si02 . Future efforts will focus on improv-
ing the photo-stability. 
Flow cytometry is a commonly used biological/biomedical 
15 research tool and the ability of the fluorescent FITC-ZnO 
particles for use with this technique was carefully investi-
gated (FIG. 5). FIG. 5 (panels labeled A-D) shows flow 
cytometry examination of FITC-ZnO particles. The data for 
FITC-ZnO particles taken (FIG. SA) immediately after dis-
20 persing in oxygen-free water, (FIG. 5B) after keeping in 
oxygen-rich water for 2 months and (FIG. 5C) after exposure 
to a mercury lamp for 2 h. Nanoparticle aggregates were gated 
based on their forward scatter and side scattering light prop-
erties on a log scale with collection of 10,000 events. This 
25 identical gating region was subsequently used to determine 
the relative mean FLI fluorescence signal ofFITC-ZnO par-
ticles after various treatments. Unlabeled ZnO particles were 
used as the control sample in these experiments and numbers 
inside parenthesis indicate mean fluorescence intensity (MFI) 
30 ofFITC-ZnO particles. 
A high percentage (98%) of the freshly synthesized FITC-
ZnO particle aggregates dispersed in oxygen-free water was 
derivatively fluorescent. As shown in FIG. Sa, a strong fluo-
rescent signal (mean fluorescence intensity, MFI=208.2) was 
35 observed in freshly prepared FITC encapsulated particle 
aggregates compared to the unlabeled pure ZnO particles. 
Long tern protection against photobleaching was also inves-
tigated using flow cytometry (FIG. 5, panels labeled A-C). 
For these experiments, FITC-ZnO particles were either kept 
40 in oxygen-rich water for a significantly longer period of two 
months (FIG. 5B) or illuminated for 2 h with a mercury lamp 
and then dispersed in oxygen-rich water media (FIG. 5C). 
Based on comparisons of the fluorescence intensities to 
freshly prepared FITC-ZnO particle aggregates (FIG. SA, 
45 MFI 208.2), the fluorescence signal remained considerably 
stable (between 59-72%) either after storage for two months 
(FIG. 5B, MFI 149.5) or exposure to strong light (FIG. 5C, 
MFI 123) suggesting the vital role of the Si02-ZnO shell in 
protecting the dye from bleaching. 
50 Biomedical Applications, Cell Imaging, Particle Uptake and 
Selective Toxicity: 
We demonstrate the ability of FITC-ZnO particles for 
potential use in four novel biomedical applications-(i) cell 
imaging, (ii) eukaryotic cellular uptake of particles, (iii) anti-
55 bacterial treatment and (iv) cancer treatment. Dye encapsu-
lated silica particles have been used in the past for biological 
imaging by attaching cell specific antibodies on the outer 
silica surface. For example, Ow et a!. have successfully 
labeled rat basophilic leukemia mast cells using antibody 
60 (immunoglobulin E) adsorbed fluorescent silica particles and 
the FceRI receptor available on these cells. It is often desir-
able to observe markers for extended periods of time against 
the background of intrinsic cellular emissions. Accordingly, 
we have investigated the ability ofFITC-ZnO particles (at 7.5 
65 flglmL) dispersed in saline medium to image E. coli using the 
green fluorescence of the particles (FIG. 6). E. coli cells were 
simultaneously stained with FITC-doped ZnO particles 
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(green fluorescence), and the vital dye (propidium iodide 
(PI), red fluorescence). PI uptake by bacterial cells is depen-
dent on loss of cell membrane integrity and is, therefore, 
frequently used to indicate the extent of death in a cell popu-
lation. Bacteria co-treated withFITC-ZnO and PI were exam- 5 
ined by confocal microscopy to establish the ability of the 
FITC-ZnO particles to stain/visualize bacterial cells (FIG. 6). 
FIG. 6 (panels labeledA-C) shows cell imaging with FITC-
ZnO particles. Confocal fluorescence microscopic images of 
12 
nm. FIGS. 7B-D show consecutive cell images/slices of a 
single cell. In FIG. 7C, an internalized particle of expected 
200 nm size is indicated by an arrow and orthogonal viewing 
was used to confirm particle intracellular localization. 
FIG. 7 shows consecutive three-dimensional slices through 
a single lurkat T cell (panels B-D) demonstrating the inter-
nalization of a green fluorescent FITC-ZnO particle with 
intracellular localization being confirmed by viewing along 
orthogonal directions (not shown). Individual confocal image 
slices were taken at intervals of 200 nm thickness (compa-
rable in size to the NP), thus only one internalized particle is 
shown in the presented focal plane. However, at least six 
internalized NP were observed in this particular cell with 
additional internalizations likely but too proximate to the 
E. coli cells simultaneously treated with FITC-doped ZnO 10 
particles (green fluorescence) and propidium iodide (PI, red 
fluorescence), showing (FIG. 6A) fluorescence signal from 
FITC-ZnO, (FIG. 6B) fluorescence signal from PI, and (FIG. 
6C) overlay ofFITC-doped ZnO and PI signals, yellow cells 
indicate dual stained cells. 
Such a bivariate analysis allows for the discrimination of 
intact cells (FITC only) and dead/non-viable cells (FITC and 
PI). Visualization of the FITC-ZnO signal alone indicates that 
the FITC-ZnO particles were associated with the bacterial 
cells and emitting very bright green fluorescence (FIG. 6A). 
Visualization of PI signal alone indicated presence of E. coli 
cells with damaged and permeable cell membranes (FIG. 
6B). By overlaying the FITC-ZnO and PI signals, a third 
image was generated where E. coli cells stained with both 
FITC-ZnO and PI appear yellow (FIG. 6C). The confocal 
images clearly demonstrate that FITC-ZnO particles have an 
excellent ability to image cells using common imaging tech-
niques if they can be attached to cells of interest. This image 
indicates that many of the FITC-ZnO associatedE. coli cells 
are still viable (i.e. not many yellow cells in panel C) even 30 
though the FITC-ZnO particles can be toxic to E. coli cells. 
This is likely due to the short incubation time (15 minutes) 
used to prepare the cells for imaging. The granular appear-
ance of the E. coli cells (FIG. 6A) is due to the particulate 
nature of the FITC-ZnO. As discussed above the FITC-ZnO 35 
15 plasma membrane to accurately resolve. The presence of such 
internalized FITC-ZnO particles was confirmed in multiple 
cells present on the culture slide. The image in panel A reflects 
NP background staining and was obtained by treating a cham-
berslide with an identical concentration of NP and sample 
20 washing regime as for cell cultures. It is important to note that 
the goal of this particular study was to specifically show NP 
uptake and intracellular localization in intact T cells follow-
ing a short NP exposure prior to extensive cytotoxicity being 
manifested in contrast to simply observing NP association 
25 with cells (either extracellular or intracellular) as performed 
for FIG. 6. Although no attempt has been made in this work to 
ascertain the specific intracellular locations of the internal-
ized particles, this important topic will be the subject matter 
offuture studies. 
particles are -200 nm in diameter and close to the resolution 
We have recently shown that ZnO nanoparticles can selec-
tively kill certain bacteria including E. coli and S. aureus. 
Here we demonstrate a similar ability ofFITC-ZnO particles 
to inhibit the growth of these two organisms. FIG. SA shows 
the number of bacterial colony forming units (CFU) produced 
by E. coli and S. aureus, after being grown in the presence of 
FITC-ZnO particles overnight. FITC-ZnO particles pre-
vented growth of E. coli at concentrations ~500 flglmL, 
whereas concentrations ~250 flg/mL prevented growth of S. 
aureus. The relative difference in toxicity ofFITC-ZnO par-
of the confocal microscope. The granular appearance of theE. 
coli cells is likely due to adherence of the particles to the 
external surface of the cells and the ability of the microscope 
to resolve individual fluorescent particles or groups of par-
ticles. It may be noted that the purpose of this experiment is 
only to demonstrate the potential ofFITC-ZnO particles as a 
fluorescence probe and not to demonstrate selectivity in the 
cell-nanoparticle (FITC-ZnO) interaction. For many cell 
types, binding of cell specific antibodies might be necessary 
for selective cell imaging applications. 
40 ticles to E. coli and S. aureus is similar to that previously 
reported by our group for ZnO nanoparticles, 11 thus suggest-
ing that the FITC-ZnO particles retain bacterial toxicity simi-
1ar to the pure ZnO nanoparticles. Additional, time dependent 
exposures were conducted by enumerating CFU of E. coli 
45 after 0, 6,12,24 and 48 hours ofFITC-ZnO particle exposure 
(FIG. SB). Exposure to FITC-ZnO particles resulted in cell 
death at concentrations of 800 flg/mL with number of viable 
bacterial cells reduced to below 99.9% of the initial CFU/mL 
Given that the size of the FITC-doped particles (-200 nm) 
described in this study and the diameter of the imaged bacte-
rial cells (-500 nm) are near the resolution capabilities of the 
microscope, nanoparticle uptake and internalization studies 
were performed on eukaryotic lurkat T cells as an example 
system. The cells were treated with FITC-ZnO particles 
(green fluorescence) for 8 h, and then washed extensively to 
remove unattached extracellular particles and reduce back-
ground staining. Cells were then stained with a PE-conju- 55 
gated antibody directed against the CD3 membrane-bound 
protein (red fluorescence) and confocal images taken using 
live cells to avoid internalization artifacts resulting from cell 
fixation. FIG. 7 (panels labeled A-D) shows uptake ofFITC-
ZnO particles by lurkat cancer cells. Confocal fluorescence 60 
microscopic images of lurkat cancer cells treated with 0.25 
mM FITC-ZnO particle (green fluorescence) for 8 hours and 
stained with a PE-conjugated antibody specific to CD3 cell 
surface protein (red fluorescence) with extensive washing to 
remove extracellular NP. FIG. 7A depicts FITC-ZnO par- 65 
ticles alone (after identical washing steps as samples contain-
ing cells) with an arrow indicating a typical particle of -200 
within 12 hours. Viable cells were completely absent after 48 
50 hours of treatment. 
We have also recently determined that ZnO nanoparticles 
show no significant toxicity to primary human T cells. To 
determine whether FITC encapsulated particles with nanos-
cale ZnO outer surface can retain the ability of differentially 
killing cancer cells, new experiments were conducted. Flow 
cytometry was used to determine the number of viable human 
cancerous T cells compared to normal primary T cells after 
exposure to FITC-ZnO particles for 24 h. FIG. S shows con-
centration and time dependent cytotoxicity ofFITC-ZnO par-
ticles for bacterial systems. In FIG. SA, E. coli and S. aureus 
cells were plated on LB media containing varying concentra-
tions ofFITC-ZnO particles and incubated at 37° C. for 24 h. 
Bars represent means±standard errors (n=3), ND indicates 
concentrations at which no bacterial colonies were detected 
after 48 h of incubation. In FIG. SB, there is shown effect of 
ZnO NP exposure time on the viability and growth of E. coli. 
(Plot presents mean CFU/mL (±standard error, n=3) of E. 
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Coli exposed to 800 flg/L FITC-ZnO particles for 0,6,12,24, 
and 48 hours, and * in the figure indicates measured ZnO 
concentrations at which no CFU counts of E. coli were 
observed.) 
FIG. 9 shows that FITC-ZnO particles reduced cell viabil-
ity of lurkat T leukemia cells to 8% at concentrations ~80 
flg/mL, whereas the viability of normal CD4+ T cells at this 
concentration remained at -61 %. Importantly, the differential 
toxicity ofFITC-ZnO particles to cancerous and normal body 
cells is similar to observations in our lab involving unlabeled 10 
ZnO nanoparticles and indicates a potential new utility of 
ZnO nanoparticles in the treatment of human cancers. 
The novel biomedical applications---cell imaging, antibac-
terial treatment and cancer treatment---ofthe FITC-ZnO par-
ticles were conducted primarily to demonstrate their multi- 15 
functional nature. The performance of these particles in the 
above demonstrated applications could be further enhanced 
by improving the quality and properties of these particles 
such as the particle size, uniformity, concentration of FITC 
molecules per particles among others and these aspects will 20 
be addressed in future studies. 
14 
3. Ability to preferentially kill cancer cells without com-
parable effects on normal human immune cells, suggest-
ing its potential for nanomedicinal applications. 
In addition the nanoscale ZnO layer might also offer new 
opportunities in the fluorescence detection of biomolecules 
by acting as a high surface area sensor platform. The UV 
fluorescence of the incorporated ZnO layer and the internal 
FITC fluorescence might provide new opportunities to detect 
and quantifY surface attached biological and chemical spe-
cies. Thus the multifunctional ZnO based fluorescent par-
ticles offers wide ranging opportunities in the nano-bio-tech-
nology applications. 
Although this invention has been described above with 
reference to particular means, materials, and embodiments, it 
is to be understood that the invention is not limited to these 
disclosed particulars, but extends instead to all equivalents 
within the scope of the following claims. 
The invention claimed is: 
1. A composition of matter comprising a fluorescent dye 
core nanostructure with a nanoscale ZnO surface layer. 
CONCLUSIONS 
We have successfully developed fluorescent particles with 
a nanoscale ZnO finishing layer using a novel one-pot syn-
thesis methodology. Although dye encapsulated fluorescent 
core-shell Si02 particles have been successfully synthesized 
2. The composition of claim 1 wherein the combination of 
the core nanostructure and nanoscale surface layer are about 
25 200nm. 
in the past with or without a metal layer on the outer surface, 
this is the first time a semiconducting oxide layer, nanoscale 30 
ZnO, has been attached to the particles. A variety of charac-
terization studies, most notably systematic XPS measure-
ments after sputter removing nanometer thick layers, con-
firmed the presence of the multi-layered architecture in the 
order ZnO-Si02 -FITC as we proceed from the surface to the 35 
core of the -200 nm sized particles. Such direct experimental 
confirmation of the multi-layered structure in core-shell par-
ticles has not been demonstrated in the past. Optical studies 
confirmed the ability of the ZnO based core-shell particles to 
improve the environmental and photostability of the fluores- 40 
cent dye. This makes these particles very useful for imaging 
cells using their relatively stable fluorescent emission. 
The additional ZnO layer in our core-shell particles opens up 
a variety of applications using the attractive physical and 
chemical properties of nanoscale ZnO including the follow- 45 
ing novel features demonstrated in this work: 
1. Fluorescence probe for biological applications such as 
cell imaging and particle tracking. 
2. Selective toxicity to bacteria suggesting their potential 
for antibacterial applications. 
3. The composition of claim 1 wherein the ZnO surface 
layer is about 10 nm. 
4. A method of making a fluorescent dye core nanostruc-
ture with a nanoscale ZnO surface layer, the method compris-
ing successive hydrolysis and condensation of organic dye 
molecules incorporating silicate and a zinc salt. 
5. The method of claim 4 wherein the organic dye mol-
ecules comprise fluorescein isothiocyanate. 
6. A method of making a fluorescent dye core nanostruc-
ture with a nanoscale Zn surface layer comprising: 
first forming organic dye molecules encapsulated by Si02 
by micro-emulsion; and 
then coating the Si02 -encapsulated organic dye molecules 
with a ZnO layer by hydrolysis of a zinc salt. 
7. The method of claim 6 wherein the organic dye mol-
ecules comprise fluorescein isothiocyanate. 
8. A method of killing cancer cells using a fluorescent dye 
core nanostructure with a nanoscale ZnO surface layer while 
monitoring the nanostructure with a fluorescence detector. 
9. A method of killing bacteria cells using a fluorescent dye 
core nanostructure with a nanoscale ZnO surface layer while 
monitoring the nanostructure with a fluorescence detector. 
* * * * * 
